The African Street Journal Libya
About

Emmaus expands in Libya through drug distribution deal

The American biopharmaceutical company has signed an exclusive distribution agreement with a Libyan pharmaceutical importer to grow its presence in the country.

Emmaus, an American biopharmaceutical company, has entered into an exclusive distribution agreement with the National International Company for Pharmaceuticals and Medical Supplies to strengthen its commercial presence in Libya. The US website Stock Titan reported the partnership, saying it aims to expand Emmaus's international footprint and boost its position in the market.

The agreement makes the Libyan company the exclusive distributor for Emmaus in Libya, so Emmaus products will reach the market through a single local partner. The report gives no details on which products are covered or when distribution will begin.

The deal adds Libya to the list of markets where Emmaus is seeking a larger share, according to the report, which does not describe the size of the Libyan market or the terms of the agreement.

Why it mattersEmmaus medicines in Libya will now move through one exclusive local distributor, which determines who supplies them to pharmacies and hospitals.